Pliant Therapeutics logo

Pliant Therapeutics Share Price Today

(NASDAQ: PLRX)

Pliant Therapeutics share price is $1.46 & ₹124.78 as on 18 Apr 2025, 2.30 'hrs' IST

$1.46

0.02

(1.39%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Pliant Therapeutics share price in Dollar and Rupees. Guide to invest in Pliant Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pliant Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Pliant Therapeutics share price movements

  • Today's Low: $1.41
    Today's High: $1.50

    Day's Volatility :5.69%

  • 52 Weeks Low: $1.10
    52 Weeks High: $16.52

    52 Weeks Volatility :93.34%

Pliant Therapeutics (PLRX) Returns

PeriodPliant Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-86.81%
-2.8%
0.0%
6 Months
-90.04%
-11.0%
0.0%
1 Year
-88.34%
-1.9%
0.0%
3 Years
-78.37%
-1.5%
-12.9%

Pliant Therapeutics (PLRX) Key Statistics

in dollars & INR

Previous Close
$1.44
Open
$1.43
Today's High
$1.495
Today's Low
$1.41
Market Capitalization
$89.4M
Today's Volume
$757.2K
52 Week High
$16.52
52 Week Low
$1.1001
Revenue TTM
$0.0
EBITDA
$-226.2M
Earnings Per Share (EPS)
$-3.47
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-54.09%

How to invest in Pliant Therapeutics Stock (PLRX) from India?

It is very easy for Indian residents to invest directly in Pliant Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pliant Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pliant Therapeutics or PLRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pliant Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pliant Therapeutics shares which would translate to 0.585 fractional shares of Pliant Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pliant Therapeutics, in just a few clicks!

Returns in Pliant Therapeutics (PLRX) for Indian investors in Rupees

The Pliant Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pliant Therapeutics investment value today

Current value as on today

₹14,002

Returns

₹85,998

(-86%)

Returns from Pliant Therapeutics Stock

₹88,339 (-88.34%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Pliant Therapeutics (PLRX)

-81%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Pliant Therapeutics Stock from India on INDmoney has decreased by -81% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Pliant Therapeutics

  • Deep Track Capital, LP

    9.75%

  • BlackRock Inc

    8.46%

  • T. Rowe Price Associates, Inc.

    7.57%

  • FMR Inc

    6.33%

  • Vanguard Group Inc

    5.27%

  • Paradigm Biocapital Advisors LP

    5.22%

Analyst Recommendation on Pliant Therapeutics

Rating
Trend

Buy

    95%Buy

    5%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Pliant Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Pliant Therapeutics Stock (PLRX)

What analysts predicted

Upside of 589.21%

Target:

$10.06

Current:

$1.46

Insights on Pliant Therapeutics Stock (Ticker Symbol: PLRX)

  • Price Movement

    In the last 7 days, PLRX stock has moved up by 7.5%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 248.0K → 4.83M (in $), with an average increase of 94.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -57.76M → -49.73M (in $), with an average increase of 16.2% per quarter
  • PLRX vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 164.6%
  • PLRX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 108.2%

Pliant Therapeutics Technicals Summary

Sell

Neutral

Buy

Pliant Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Pliant Therapeutics (PLRX) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Pliant Therapeutics Inc logo
-8.86%
-90.04%
-88.34%
-78.37%
-93.15%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Pliant Therapeutics

Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Organization
Pliant Therapeutics
Employees
171
CEO
Dr. Bernard Coulie M.B.A., M.D., Ph.D.
Industry
Health Technology

Management People of Pliant Therapeutics

NameTitle
Dr. Bernard Coulie M.B.A., M.D., Ph.D.
President, CEO & Director
Dr. Keith Lamont Cummings M.B.A., M.D.
Chief Financial Officer
Mr. Mike Ouimette J.D.
Chief Legal & Compliance Officer and Secretary
Mr. Johannes P. Hull
Chief Business Officer
Dr. Eric A. Lefebvre M.D.
Chief Medical Officer
Dr. Rik Derynck Ph.D.
Scientific Founder & Member of Scientific Advisory Board
Mr. Dean Sheppard M.D.
Scientific Founder & Member of Scientific Advisory Board
Mr. Bill DeGrado Ph.D.
Scientific Founder & Member of Scientific Advisory Board
Mr. Hal Chapman M.D.
Scientific Founder & Member of Scientific Advisory Board
Ms. Delphine Imbert Ph.D.
Chief Technical Officer

Important FAQs about investing in PLRX Stock from India :

What is Pliant Therapeutics share price today?

Pliant Therapeutics share price today stands at $1.46, Open: $1.43 ; Previous Close: $1.44 ; High: $1.50 ; Low: $1.41 ; 52 Week High: $16.52 ; 52 Week Low: $1.10.

The stock opens at $1.43, after a previous close of $1.44. The stock reached a daily high of $1.50 and a low of $1.41, with a 52-week high of $16.52 and a 52-week low of $1.10.

Can Indians buy Pliant Therapeutics shares?

Yes, Indians can invest in the Pliant Therapeutics (PLRX) from India.

With INDmoney, you can buy Pliant Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pliant Therapeutics at zero transaction cost.

How can I buy Pliant Therapeutics shares from India?

It is very easy to buy Pliant Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pliant Therapeutics (PLRX) be purchased?

Yes, you can buy fractional shares of Pliant Therapeutics with INDmoney app.

What are the documents required to start investing in Pliant Therapeutics stocks?

To start investing in Pliant Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pliant Therapeutics Stock (PLRX)?

Today’s highest price of Pliant Therapeutics (PLRX) is $1.50.

Today’s lowest price of Pliant Therapeutics (PLRX) is $1.41.

What is today's market capitalisation of Pliant Therapeutics?

Today's market capitalisation of Pliant Therapeutics PLRX is 89.4M

What is the 52 Week High and Low Range of Pliant Therapeutics Stock (PLRX)?

  • 52 Week High

    $16.52

  • 52 Week Low

    $1.10

What are the historical returns of Pliant Therapeutics (PLRX)?

  • 1 Month Returns

    -8.86%

  • 3 Months Returns

    -90.04%

  • 1 Year Returns

    -88.34%

  • 5 Years Returns

    -93.15%

Who is the Chief Executive Officer (CEO) of Pliant Therapeutics ?

Dr. Bernard Coulie M.B.A., M.D., Ph.D. is the current Chief Executive Officer (CEO) of Pliant Therapeutics.